Latuda and INSOMNIA

1,012 reports of this reaction

2.4% of all Latuda reports

#9 most reported adverse reaction

Overview

INSOMNIA is the #9 most commonly reported adverse reaction for Latuda, manufactured by Sumitomo Pharma America, Inc.. There are 1,012 FDA adverse event reports linking Latuda to INSOMNIA. This represents approximately 2.4% of all 42,043 adverse event reports for this drug.

Patients taking Latuda who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

INSOMNIA1,012 of 42,043 reports

INSOMNIA is a less commonly reported adverse event for Latuda, but still significant enough to appear in the safety profile.

Other Side Effects of Latuda

In addition to insomnia, the following adverse reactions have been reported for Latuda:

Frequently Asked Questions

Does Latuda cause INSOMNIA?

INSOMNIA has been reported as an adverse event in 1,012 FDA reports for Latuda. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is INSOMNIA with Latuda?

INSOMNIA accounts for approximately 2.4% of all adverse event reports for Latuda, making it a notable side effect.

What should I do if I experience INSOMNIA while taking Latuda?

If you experience insomnia while taking Latuda, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.